Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression

Phase 3 Terminated 25 enrolled Lindner Center of HOPE Shire · collab University of Cincinnati · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The specific aim of this study is to evaluate the efficacy and tolerability of a stimulant (lisdexamfetamine) in the adjunctive treatment of bipolar disorder.

Timeline

Start: 2010-01
Primary completion: 2014-02
Completion: 2014-02

Publications

Results McElroy SL, Martens BE, Mori N, Blom TJ, Casuto LS, Hawkins JM, Keck PE Jr. Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo-controlled trial. Int Clin Psychopharmacol. 2015 Jan;30(1):6-13. doi: 10.1097/YIC.0000000000000051.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Lisdexamfetamine	Other / unclassified	20 mg	Oral
Comparator	Lisdexamfetamine	Other / unclassified	70 mg	Oral

Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression

Summary

Timeline

Publications

Drugs

Indications